The assets being acquired by ICI Pakistan through the transaction include a Wyeth Pakistan-owned pharmaceutical manufacturing facility in Karachi along with some popular and well-established products and registrations.
In addition, two products and registrations of Pfizer Pakistan are also included in the acquisition, it added. The transaction is now set to move ahead, subject to requisite regulatory approvals.
Published in The Express Tribune, May 23rd, 2017.
Like Business on Facebook, follow @TribuneBiz on Twitter to stay informed and join in the conversation.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ